New weight loss pill
The U.S. Food and Drug Administration just recently approved another prescription medical weight loss drug, Qsymia (previously named Qnexa), which is said to produce significant weight loss.
Qsymia: The facts
In clinical trials, patients experienced a more dramatic weight loss with Qsymia than with Belviq, another weight loss drug that recently got FDA approval*. Patients in the trial went from an average of 227 pounds to 204 pounds while on Qsymia. Those on Belviq went from an average of 220 to 207.
Meant for obese or overweight patients with a BMI of 27 or greater who suffer from hypertension and diabetes, Qsymia’s benefits include lowered blood pressure and cholesterol levels in obese people and less chance of getting Type 2 diabetes while on the drug. It also contains phentermine, an appetite suppressant.
Possible side effects include an increased heart rate and birth defects when taken by pregnant women. Qsymia is expected to be available soon, while its manufacturer, Vivus, will conduct a study on its cardiovascular effects, as required by the FDA.
Consult with Dr Aron
Visit her website WeightLossNYC™ today, or call 718-491-5525 for your first appointment with a knowledgeable medical weight loss physician, Oksana Aron MD.
Sources: cnn.com, Images: FreeDigitalPhotos.net
*Belviq withdrawn from market Feb 2020.